中晚期鼻咽癌,advanced nasopharyngeal carcinoma
1)advanced nasopharyngeal carcinoma中晚期鼻咽癌
1.Preliminary report of late course accelerated hyperfractionated radiotherapy foradvanced nasopharyngeal carcinoma;中晚期鼻咽癌后程加速超分割放疗的近期疗效观察
英文短句/例句
1.Clinical study of radiotherapy plus chemotherapy for median and advanced nasopharyngeal carcinoma中晚期鼻咽癌同期放化疗的临床研究
2.Clinical effect of concurrent chemoradiotherapy in patients with advanced nasopharyngeal carcinoma同期放化疗治疗中晚期鼻咽癌的疗效观察
3.The effect of comprehensive treatment with radiotherapy and chemotherapy in locally advanced nasopharyngeal cancer放化疗综合治疗局部中晚期鼻咽癌的疗效观察
4.A clinical study of response of concurrent radio-chemotherapy in cases with advanced nasopharyngeal carcinoma中晚期鼻咽癌同步放化疗临床疗效观察
5.A Phase Ⅲ Study of Induction Chemotherapy and Radiotherapy Concomitant HCFU Chemotherapy in Local Advanced Nasopharyngeal Carcinoma;诱导化疗和放疗同期卡莫氟化疗治疗中晚期鼻咽癌Ⅲ期临床研究
6.Preliminary Report of Late Course Accelerated Hyperfractionated Radiotherapy for Advanced Nasopharyngeal Carcinoma;中晚期鼻咽癌后程加速超分割放疗的近期疗效观察
7.Study of Induction Chemotherapy Plus Concurrent Chemoradiotherapy Versus Radiotherapy Alone in Paients with Locoregionally Advanced Nasopharyngeal Carcinoma诱导加同期放化疗治疗局部中晚期鼻咽癌的临床研究
8.Short-term therapeutic effect for induction chemotherapy and radiotherapy in 42 cases of advanced nasopharyngeal carcinoma诱导化疗联合放疗42例中晚期鼻咽癌近期疗效观察
9.Clinical study on SMART and concurrent chemotherapy for locally advanced nasopharyngeal carcinomas同期推量调强放疗联合化疗治疗中晚期鼻咽癌的疗效分析
10.Intraarterial Infusion Chemotherapy Combined with Three-dimensional Conformal Radiotherapy for Local Advanced Nasopharyngeal Carcinoma;介入动脉灌注化疗联合放疗对中晚期鼻咽癌治疗的研究
11.The clincal observation on the effect of advanced nasopharyngeal carcinoma treated by Docetaxel combined with radiotherapy多西紫杉醇联合放疗治疗中晚期鼻咽癌临床观察
12.Chemotherapy regimens of gemcitabine plus cisplatin sequently combined with radiotherapy for advanced nasopharyngeal carcinomaGP方案序贯化疗放疗治疗中晚期鼻咽癌的初步观察
13.Efficacy of Chemotherapy Combined with Radiotherapy versus Radiotherapy Alone for 65 Cases with Locally Advanced Nasopharyngeal Carcinoma联合放化疗与单纯放疗治疗65例局部中晚期鼻咽癌比较研究
14.Concurrent Chemoradiotherapy with Cisplatin for Local Advanced Nasophargngeal Carcinoma顺铂在局部晚期鼻咽癌同步放化疗中的应用
15.Prospective Clinical Study of chemotherapy combined with radiotherapy in treatment of advanced nasopharyngeal carcinoma晚期鼻咽癌同期放化疗临床疗效分析
16.Concurrent Chemoradiotherapy for 40 Cases with Locally Advanced Nasopharyngeal Carcinoma同步放化疗治疗局部晚期鼻咽癌40例
17.Neoadjuvant chemotherapy,adjuvant chemotherapy and radiotherapy or their combinations for nasopharyngeal cancer:a Meta-analysis on randomized controlled trials放、化疗治疗局部晚期鼻咽癌的Meta分析
BINATION OF RADIOTHERAPY AND PINGYA- NGMYCIN IN ADVANCED NASOPHARYNGEAL CANCER-Report on 40 patients放疗并用平阳霉素治疗晚期鼻咽癌40例
相关短句/例句
Advanced Nasopharyngeal Carcinoma晚期鼻咽癌
1.Clinical Study of Paolitexel plus Cisplatin in the Treatment ofAdvanced Nasopharyngeal Carcinoma;紫杉醇联合顺铂治疗48例晚期鼻咽癌近期疗效分析
2.Objective:To evaluate the efficacy of concurrent chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma.目的:观察同期放化疗治疗晚期鼻咽癌的疗效。
3)nasopharyngeal carcinoma晚期鼻咽癌
1.Clinical study of combination of paclitaxel、cisplantin and 5-fluorouracil in the treatment of advancednasopharyngeal carcinoma.;紫杉醇联合顺铂、5-氟尿嘧啶治疗晚期鼻咽癌的临床观察
4)StageⅢ ⅣA nasopharyngeal carcinoma局部中晚期鼻咽癌
5)loco-regional advanced nasopharyngeal局部晚期鼻咽癌
1.A randomized clinical control study on weekly concurrent chemoradiotherapy with oxaliplatin or cisplatin in the treatment ofloco-regional advanced nasopharyngeal carcinoma每周奥沙利铂或顺铂同期放化疗治疗局部晚期鼻咽癌的随机对照研究
6)Early nasopharyngeal carcinoma早期鼻咽癌
延伸阅读
鼻咽癌鼻咽癌nasopharyngealcarcinoma发生于鼻咽粘膜的恶性肿瘤。中国的广东、广西、福建、湖南等地为多发区，男多于女。发病年龄大多为中年人，亦有青少年患病者。病因与种族易感性（黄种人较白种人患病多）、遗传因素及EB病毒感染等有关。鼻咽癌恶性程度较高，早期即可出现颈部淋巴结转移。临床特点为4大症状：①鼻部症状。一侧鼻堵，鼻出血，早期可仅有鼻涕带血或吸涕带血。②颈部肿块。半数以上的患者在确诊时已有淋巴结转移，不少患者以颈部肿物作为首发症状，肿块多位于颈侧部上方，质硬，活动度差。③颅神经症状。肿瘤可沿颅底向颅内侵犯，侵犯多个颅神经，一侧头痛和复视可于疾病较早期出现。④耳部症状。一侧耳闷、耳聋或反复耳堵塞感等。鼻咽腔位置隐匿，早期症状模糊，当患者出现一侧鼻出血、吸涕带血、一侧耳闷、一侧头痛、复视和颈部肿物时，应及时就医，反复检查。EB病毒血清学检查、X射线摄影、CT检查、MRI检查等可协助诊断，确诊还须由鼻咽部肿物采取活检经病理组织学证实，有时需要反复多次活检才能确定。鼻咽癌诊断确立后，应尽早施行放射治疗，足量不间断的放疗配合中医中药、升白细胞药物等的治疗，可使半数以上患者获5年以上生存时间。
